---
reference_id: "PMID:11014973"
title: Antiphospholipid syndrome.
authors:
- Gromnica-Ihle E
- Schössler W
journal: Int Arch Allergy Immunol
year: '2000'
doi: 10.1159/000024425
content_type: abstract_only
---

# Antiphospholipid syndrome.
**Authors:** Gromnica-Ihle E, Schössler W
**Journal:** Int Arch Allergy Immunol (2000)
**DOI:** [10.1159/000024425](https://doi.org/10.1159/000024425)

## Content

1. Int Arch Allergy Immunol. 2000 Sep;123(1):67-76. doi: 10.1159/000024425.

Antiphospholipid syndrome.

Gromnica-Ihle E(1), Schössler W.

Author information:
(1)Medical Center for Rheumatology, Berlin, Germany. 
gromnica-ihle@berlin.snafu.de

Antiphospholipid syndrome (APS) is a disease characterized by venous and 
arterial thromboses or spontaneous abortions and the repeated detection of 
antiphospholipid antibodies (aPL). APS may be associated with another autoimmune 
disease (secondary APS), particularly systemic lupus erythematosus (SLE), or 
unrelated to an underlying disease (primary APS). APS affects almost all organs. 
In addition to the clinical criteria, lupus anticoagulant testing and 
immunological aPL determinations are required to establish the diagnosis of APS.

Copyright 2000 S. Karger AG, Basel.

DOI: 10.1159/000024425
PMID: 11014973 [Indexed for MEDLINE]